v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-In-Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Redeemable Convertible Preferred Stock
Beginning balance at Dec. 31, 2024 $ (292,402)   $ 28,368 $ (320,250) $ (520)  
Beginning balance, (in shares) at Dec. 31, 2024   434,720        
Beginning balance at Dec. 31, 2024           $ 378,150
Beginning balance (in shares) at Dec. 31, 2024           341,496,158
Exercise of stock options 175   175      
Exercise of stock options (in shares)   15,962        
Stock-based compensation 1,616   1,616      
Currency translation adjustment 80       80  
Net Income (Loss) (16,780)     (16,780)    
Ending balance at Jun. 30, 2025           $ 378,150
Ending balance (in shares) at Jun. 30, 2025           341,496,158
Ending balance at Jun. 30, 2025 (307,311)   30,159 (337,030) (440)  
Ending balance, (in shares) at Jun. 30, 2025   450,682        
Beginning balance at Mar. 31, 2025 (299,717)   29,367 (328,534) (550)  
Beginning balance, (in shares) at Mar. 31, 2025   448,541        
Beginning balance at Mar. 31, 2025           $ 378,150
Beginning balance (in shares) at Mar. 31, 2025           341,496,158
Exercise of stock options 27   27      
Exercise of stock options (in shares)   2,141        
Stock-based compensation 765   765      
Currency translation adjustment 110       110  
Net Income (Loss) (8,496)     (8,496)    
Ending balance at Jun. 30, 2025           $ 378,150
Ending balance (in shares) at Jun. 30, 2025           341,496,158
Ending balance at Jun. 30, 2025 (307,311)   30,159 (337,030) (440)  
Ending balance, (in shares) at Jun. 30, 2025   450,682        
Beginning balance at Dec. 31, 2025 162,459   519,610 (356,711) (440)  
Beginning balance, (in shares) at Dec. 31, 2025   18,316,928        
Issuance of common stock in connection with follow-on offering, net of deferred offering costs, underwriting discounts and commissions, Value 243,282   243,282      
Issuance of common stock in connection with follow-on offering, net of deferred offering costs, underwriting discounts and commissions (in shares)   4,936,651        
Exercise of warrants 3,010   3,010      
Exercise of warrants (in shares)   238,931        
Exercise of stock options 6,099   6,099      
Exercise of stock options (in shares)   565,239        
RSUs vested (in shares)   88,511        
Stock-based compensation 6,919   6,919      
Currency translation adjustment 189       189  
Net Income (Loss) (17,286)     (17,286)    
Ending balance at Jun. 30, 2026 404,672   778,920 (373,997) (251)  
Ending balance, (in shares) at Jun. 30, 2026   24,146,260        
Beginning balance at Mar. 31, 2026 235,159   602,416 (366,882) (375)  
Beginning balance, (in shares) at Mar. 31, 2026   21,359,204        
Issuance of common stock in connection with follow-on offering, net of deferred offering costs, underwriting discounts and commissions, Value 167,938   167,938      
Issuance of common stock in connection with follow-on offering, net of deferred offering costs, underwriting discounts and commissions (in shares)   2,300,000        
Exercise of stock options 5,009   5,009      
Exercise of stock options (in shares)   474,972        
RSUs vested (in shares)   12,084        
Stock-based compensation 3,557   3,557      
Currency translation adjustment 124       124  
Net Income (Loss) (7,115)     (7,115)    
Ending balance at Jun. 30, 2026 $ 404,672   $ 778,920 $ (373,997) $ (251)  
Ending balance, (in shares) at Jun. 30, 2026   24,146,260